Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/CE

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EV/CE History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EV/CE(x) -0.030.06-0.07-0.050.04

What is the latest EV/CE ratio of MANKIND PHARMA ?

The latest EV/CE ratio of MANKIND PHARMA is -0.03 based on Mar2023 Consolidated results.
Year EV/CE
Mar2023-0.03
Mar20220.06
Mar2021-0.07
Mar2020-0.05
Mar20190.04

How is EV/CE of MANKIND PHARMA Trending?

Years EV/CE % Change
Mar2023 -0.03
Negative
Mar2022 0.06
Positive
Mar2021 -0.07
Negative
Mar2020 -0.05
Negative
Mar2019 0.04 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/CE ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹84,398.4 Cr -4.8% -10.7% 55.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹369,570.0 Cr 0.9% 1.2% 63.5% Stock Analytics
CIPLA ₹119,627.0 Cr 2.7% 7.3% 52% Stock Analytics
ZYDUS LIFESCIENCES ₹108,316.0 Cr 9.1% 18% 112.8% Stock Analytics
DIVIS LABORATORIES ₹107,804.0 Cr 3.2% 9.5% 20.2% Stock Analytics
DR REDDYS LABORATORIES ₹97,966.5 Cr -1.6% -2.7% 29.9% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-4.8%

-10.7%

55.8%

SENSEX

1.7%

1.6%

20.6%


You may also like the below Video Courses